Monitoring cognitive impairment through speech

Winterlight has developed a tablet-based assessment that is fast, objective, and stress-free. By analyzing speech alone, we can detect cognitive impairment associated with dementia and mental illness. Our assessment can be used in life science research, senior care and clinical settings.

Vocal biomarkers for use in clinical trials

Existing neurological assessments are slow, subjective, and difficult to do remotely. Winterlight’s technology can extract speech-based digital biomarkers from short snippets of speech. The Winterlight Assessment is currently used in a dozen clinical trials to track changes and identify treatment responses. We support life science partners throughout their trials for site onboarding, data collection, speech analysis, and results interpretation.

Work with us

Sign up to access our speech analysis API

We make clinically validated speech-based biomarkers easy to access and use. Our API can be used to receive analyses for speech data you have already collected, or to integrate with your app or device that continuously collects speech in order to receive fast results.

Sign up

Participate in Winterlight studies

We are researching speech patterns in people of all ages to help us build better tools for disease detection and monitoring. This will allow researchers and clinicians to better understand the signs of neurological and psychiatric disease and work towards treatment and cures. We invite you to help us by participating in our research studies.

Tell me more

Developed in partnership with:



What's new

September 9, 2021

Winterlight publishes review on the use of speech-based measures to detect depression in older adults

Winterlight published a new review paper in Frontiers in Psychiatry focussing on how natural language processing has been used to study depression in older adults.

Read Read More
July 27, 2021

Winterlight presents research on speech-based digital biomarkers in collaboration with Genentech

At the Alzheimer's Association International Conference, Winterlight Labs presented new research on how speech characteristics are associated with Alzheimer's Disease, in collaboration with Genentech.

Read Read More
June 4, 2021

Winterlight publishes new research comparing digital speech measures with clinical assessments

New research published in Alzheimer's Research & Therapy examines how automatically computed speech measures correlate with clinical assessments of speech in Alzheimer's Disease and Mild Cognitive Impairment.

Read Read More
April 30, 2021

Winterlight Labs partners with the Digital Medicine Society (DiMe) to drive adoption of digital health resources

Winterlight Labs participates in the Digital Medicine Society's Tour of Duty to develop resources for the adoption of digital measures in clinical research.

Read Read More

Get in touch

Mailing Address

Winterlight Labs
46 Hayden St
Suite 400
Toronto
Ontario, Canada
M4Y 1V8

Send us a message